ABM Investama Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? ABM Investama Tbk trades at Rp2,650 (market cap 7.3T, 135K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: ABM Investama Tbk is far larger — about 44.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and ABM Investama Tbk is more actively traded (135K versus 62.5K). Which is the better fit depends on your goals.
| ABMM | OBAT | |
|---|---|---|
Market Cap | 7.3T | 164.65B |
Volume | 135K | 62.5K |
Lot | 1.35K | 625 |
Turnover | 358.21M | 15.03M |
Average Price | 2,653.39 | 240.55 |
Value | 358.21M | 15.03M |
Indicative Equilibrium Price | 2,650 | 238 |
Indicative Equilibrium Volume | 17 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
ABM Investama, PT (the company) was established under its original name of PT Adiratna Bani Makmur on Jun 1, 2006 then changed to PT ABM Investama Tbk based on Notaries Deed dated Aug 31, 2009. The deed of establishment was approved by the the Ministry of Justice dated Oct 16, 2009. The Company’s articles of association has been amended several times, most recently by notarial deed No. 163 of Mrs. Aulia Taufani, S.H., dated Jul 21, 2011, concerning among others, public offering of stock.
Read more on ABMM →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →